H. Yagita

发表

Prevention of autoimmune insulin-dependent diabetes in non-obese diabetic mice by anti-LFA-1 and anti-ICAM-1 mAb.

K. Amano, K. Okumura, H. Yagita, 1994, International immunology.

Local production of the p40 subunit of interleukin 12 suppresses T-helper 1-mediated immune responses and prevents allogeneic myoblast rejection.

H. Wakimoto, K. Kato, H. Hamada, 1996, Proceedings of the National Academy of Sciences of the United States of America.

Targeted disruption of Traf5 gene causes defects in CD40- and CD27-mediated lymphocyte activation.

C. Ware, M. Matsumoto, S. Santee, 1999, Proceedings of the National Academy of Sciences of the United States of America.

Simultaneous blockade of programmed death 1 and vascular endothelial growth factor receptor 2 (VEGFR2) induces synergistic anti‐tumour effect in vivo

H. Yoshiji, S. Yasuda, Y. Nakajima, 2013, Clinical and experimental immunology.

A metalloproteinase inhibitor prevents lethal acute graft-versus-host disease in mice.

K. Yoshino, K. Oshimi, K. Okumura, 1997, Blood.

Preferential elimination of CD28+ T cells in systemic lupus erythematosus (SLE) and the relation with activation‐induced apoptosis

H. Hashimoto, H. Kaneko, M. Azuma, 1996, Clinical and experimental immunology.

Expression of costimulatory molecule CD40 in murine heart with acute myocarditis and reduction of inflammation by treatment with anti-CD40L/B7-1 monoclonal antibodies.

Y. Yazaki, Y. Seko, K. Okumura, 1998, Circulation research.

Soluble Fas (APO-1, CD95) and soluble Fas ligand in rheumatic diseases.

K. Okumura, H. Yagita, N. Kayagaki, 1997, Arthritis and rheumatism.

Serum levels of soluble Fas/APO‐1 (CD95) and its molecular structure in patients with systemic lupus erythematosus (SLE) and other autoimmune diseases

T. Koike, K. Okumura, M. Azuma, 1997, Clinical and experimental immunology.

Relative contribution of CD2 and LFA-1 to murine T and natural killer cell functions.

K. Okumura, H. Yagita, K. Takahashi, 1990, Journal of immunology.

Fas and its ligand in a general mechanism of T-cell-mediated cytotoxicity.

S. Yonehara, S. Hanabuchi, K. Okumura, 1994, Proceedings of the National Academy of Sciences of the United States of America.

Requirement of CD28-CD86 co-stimulation in the interaction between antigen-primed T helper type 2 and B cells.

K. Okumura, M. Azuma, H. Yagita, 1997, International immunology.

Accumulation of soluble Fas in inflamed joints of patients with rheumatoid arthritis.

T. Sumida, K. Okumura, H. Yagita, 1997, Arthritis and rheumatism.

Constitutive expression of pore-forming protein in peripheral blood gamma/delta T cells: implication for their cytotoxic role in vivo

Y. Shinkai, M. Smyth, K. Okumura, 1990, The Journal of experimental medicine.

IL-2 and IL-6 synergize to augment the pore-forming protein gene expression and cytotoxic potential of human peripheral blood T cells.

H. Young, M. Smyth, J. Ortaldo, 1990, Journal of immunology.

Fibroblast growth factor 18 stimulates the proliferation of hepatic stellate cells, thereby inducing liver fibrosis

H. Nakano, K. Ikejima, S. Ueha, 2023, Nature communications.

Perforin, a pore-forming protein detectable by monoclonal antibodies, is a functional marker for killer cells.

Y. Shinkai, K. Okumura, H. Yagita, 1990, International immunology.

Expression and function of fibronectin binding integrins on rat mast cells.

H. Hashimoto, C. Ra, K. Okumura, 1995, International immunology.

Fibronectin receptor integrins are involved in mast cell activation.

C. Ra, K. Okumura, H. Yagita, 1994, The Journal of allergy and clinical immunology.

Involvement of alpha 1 and alpha 4 integrins in gut mucosal injury of graft-versus-host disease.

M. Omata, K. Okumura, H. Yagita, 1995, International immunology.

Comparative studies of CD3- and CD3+ CD56+ cells: examination of morphology, functions, T cell receptor rearrangement, and pore-forming protein expression.

H. Young, J. Ortaldo, H. Yagita, 1991, Cellular immunology.

Activation of peripheral blood T cells via the p75 interleukin 2 receptor

K. Sugamura, K. Okumura, H. Yagita, 1989, The Journal of experimental medicine.

Beta 1 integrin-mediated interaction with extracellular matrix proteins regulates cytokine gene expression in synovial fluid cells of rheumatoid arthritis patients

H. Hashimoto, N. Miyasaka, S. Miyake, 1993, The Journal of experimental medicine.

CD28-independent costimulation of T cells by OX40 ligand and CD70 on activated B cells.

K. Takeda, K. Okumura, H. Yagita, 1999, Journal of immunology.

Expression of Fas antigen and Fas ligand in the rheumatoid synovial tissue.

H. Inoue, T. Sumida, S. Gay, 1996, Clinical immunology and immunopathology.

A murine very late activation antigen-like extracellular matrix receptor involved in CD2- and lymphocyte function-associated antigen-1-independent killer-target cell interaction.

K. Kato, Y. Hashimoto, K. Okumura, 1990, Journal of immunology.

The differential role of CD86 and CD80 co-stimulatory molecules in the induction and the effector phases of contact hypersensitivity.

K. Okumura, M. Azuma, H. Yagita, 1996, International immunology.

Blockade of NKG2D signaling prevents the development of murine CD4+ T cell-mediated colitis.

K. Tsuchiya, R. Okamoto, T. Kanai, 2008, American journal of physiology. Gastrointestinal and liver physiology.

Effects of in vivo administration of anti-B7-1/B7-2 monoclonal antibodies on murine acute myocarditis caused by coxsackievirus B3.

Y. Yazaki, Y. Seko, K. Okumura, 1998, Circulation research.

A novel role for H-Ras in the regulation of very late antigen-4 integrin and VCAM-1 via c-Myc-dependent and -independent mechanisms.

J. Udagawa, Y. Minami, H. Yamamura, 1999, Journal of immunology.

M cell-depletion blocks oral prion disease pathogenesis

I. Williams, D. S. Donaldson, N. Mabbott, 2012, Mucosal Immunology.

Relative contribution of NK and NKT cells to the anti-metastatic activities of IL-12.

L. Kaer, K. Takeda, K. Okumura, 2000, International immunology.

A critical role of VLA-4 in erythropoiesis in vivo.

K. Okumura, S. Habu, H. Yagita, 1996, Blood.

Radiotherapy Promotes Tumor-Specific Effector CD8+ T Cells via Dendritic Cell Activation

M. van den Broek, R. Schwendener, M. Pruschy, 2012, The Journal of Immunology.

Expression of CD30 ligand (CD153) on murine activated T cells.

K. Takeda, K. Okumura, H. Yagita, 1999, Biochemical and biophysical research communications.

Suppression and acceleration of autoimmune diabetes by neutralization of endogenous interleukin-12 in NOD mice.

M. Kasuga, M. Nakayama, K. Okumura, 2000, Diabetes.

The Tissue Distribution of the B7-2 Costimulator in Mice: Abundant Expression on Dendritic Cells In Situ and During Maturation In Vitro By K. Inaba,* M. Witmer-Pack,~ M. Inaba,g K. S. Hathcock, II

Bristol-Myers Squibb, Susumu Ikehara, P. S. Linsley, 1994 .

Resistance of infant leukemia with MLL rearrangement to tumor necrosis factor-related apoptosis-inducing ligand: a possible mechanism for poor sensitivity to antitumor immunity

K. Goi, S. Nakazawa, K. Okumura, 2006, Leukemia.

Fas-mediated stimulation induces IL-8 secretion by rheumatoid arthritis synoviocytes independently of CPP32-mediated apoptosis.

K. Okumura, H. Yagita, K. Nishioka, 1996, Biochemical and biophysical research communications.